Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia.

van der Geest KSM, Borg F, Kayani A, Paap D, Gondo P, Schmidt W, Luqmani RA, Dasgupta B.

Ann Rheum Dis. 2020 Jan 3. pii: annrheumdis-2019-216343. doi: 10.1136/annrheumdis-2019-216343. [Epub ahead of print]

2.

Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.

Nilsen AT, Karlsen C, Bakland G, Watts R, Luqmani R, Koldingsnes W.

Rheumatology (Oxford). 2019 Dec 20. pii: kez597. doi: 10.1093/rheumatology/kez597. [Epub ahead of print]

PMID:
31859355
3.

The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis.

Monti S, Ponte C, Pereira C, Manzoni F, Klersy C, Rumi F, Carrara G, Hutchings A, Schmidt WA, Dasgupta B, Caporali R, Montecucco C, Luqmani R.

Rheumatology (Oxford). 2019 Dec 17. pii: kez554. doi: 10.1093/rheumatology/kez554. [Epub ahead of print]

PMID:
31848610
4.

Response to 'Comment on: 'A new era for giant cell arteritis''.

Mollan SP, Quick V, Sinclair AJ, Luqmani R.

Eye (Lond). 2019 Nov 25. doi: 10.1038/s41433-019-0703-9. [Epub ahead of print] No abstract available.

PMID:
31767962
5.

Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data from an International Observational Cohort.

Gribbons KB, Ponte C, Craven A, Robson JC, Suppiah R, Luqmani R, Watts R, Merkel PA, Grayson PC.

Arthritis Rheumatol. 2019 Nov 14. doi: 10.1002/art.41165. [Epub ahead of print]

PMID:
31729185
6.

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.

Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, Dasgupta B, Dejaco C, Mahr A, Ponte C, Salvarani C, Schmidt W, Hellmich B.

RMD Open. 2019 Sep 23;5(2):e001020. doi: 10.1136/rmdopen-2019-001020. eCollection 2019.

7.

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.

Monti S, Águeda AF, Luqmani RA, Buttgereit F, Cid M, Dejaco C, Mahr A, Ponte C, Salvarani C, Schmidt W, Hellmich B.

RMD Open. 2019 Sep 16;5(2):e001003. doi: 10.1136/rmdopen-2019-001003. eCollection 2019.

8.

Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis.

Blockmans D, Luqmani R, Spaggiari L, Salvarani C.

Autoimmun Rev. 2019 Dec;18(12):102405. doi: 10.1016/j.autrev.2019.102405. Epub 2019 Oct 22. Review.

PMID:
31648043
9.

Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study.

Bischof A, Jaeger VK, Hadden RDM, Luqmani RA, Pröbstel AK, Merkel PA, Suppiah R, Craven A, Collins MP, Daikeler T.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 20;6(6). pii: e615. doi: 10.1212/NXI.0000000000000615. Print 2019 Nov.

10.

Early development of new cardiovascular risk factors in the systemic vasculitides.

Monti S, Robson J, Klersy C, Kraven A, Montecucco C, Watts R, Merkel PA, Luqmani R.

Clin Exp Rheumatol. 2019 Sep 6. [Epub ahead of print]

PMID:
31498071
11.

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis.

Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Quinn KA, Robson JC, Seo P, Sreih AG, Suppiah R, Warrington KJ, Ytterberg SR, Luqmani R, Watts R, Merkel PA, Grayson PC.

Arthritis Care Res (Hoboken). 2019 Aug 23. doi: 10.1002/acr.24055. [Epub ahead of print]

PMID:
31444857
12.

A computerised system to evaluate patients with rheumatic diseases.

Luqmani R, O'Neill L, David J.

Future Healthc J. 2019 Mar;6(Suppl 1):80-81. doi: 10.7861/futurehosp.6-1-s80. No abstract available.

13.

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA.

Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.

PMID:
31270110
14.

Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.

Gibson KM, Morishita KA, Dancey P, Moorehead P, Drögemöller B, Han X, Graham J, Hancock REW, Foell D, Benseler S, Luqmani R, Yeung RSM, Shenoi S, Bohm M, Rosenberg AM, Ross CJ, Cabral DA, Brown KL; PedVas Investigators Network.

Arthritis Rheumatol. 2019 Oct;71(10):1747-1755. doi: 10.1002/art.40913. Epub 2019 Aug 26.

PMID:
31008556
15.

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

Tomasson G, Farrar JT, Cuthbertson D, McAlear CA, Ashdown S, Cronholm PF, Dawson J, Gebhart D, Lanier G, Luqmani RA, Milman N, Peck J, Robson JC, Shea JA, Carette S, Khalidi N, Koening CL, Langford CA, Monach PA, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2019 Aug;46(8):928-934. doi: 10.3899/jrheum.171405. Epub 2019 Mar 1.

PMID:
30824648
16.

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.

Jayne D, Blockmans D, Luqmani R, Moiseev S, Ji B, Green Y, Hall L, Roth D, Henderson RB, Merkel PA; BREVAS Study Collaborators.

Arthritis Rheumatol. 2019 Jun;71(6):952-963. doi: 10.1002/art.40802. Epub 2019 Apr 16.

17.

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1316. doi: 10.1093/rheumatology/key411. No abstract available.

PMID:
30544209
18.

S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.

Brown KL, Lubieniecka JM, Armaroli G, Kessel K, Gibson KM, Graham J, Liu D, Hancock REW, Ross CJ, Benseler SM, Luqmani RA, Cabral DA, Foell D, Kessel C.

Front Pediatr. 2018 Nov 23;6:341. doi: 10.3389/fped.2018.00341. eCollection 2018.

19.

Clinical features and structured clinical evaluation of vasculitis.

Ponte C, Águeda AF, Luqmani RA.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):31-51. doi: 10.1016/j.berh.2018.10.001. Epub 2018 Nov 22. Review.

PMID:
30526897
20.

Preface.

Luqmani RA, Jayne D.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):1-2. doi: 10.1016/j.berh.2018.11.001. No abstract available.

PMID:
30526890
21.

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1123-1125. doi: 10.1093/rheumatology/key326. No abstract available.

22.

The use of ultrasound in the management of large-vessel vasculitis: an evolving concept.

Monti S, Águeda AF, Luqmani R.

Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):96-102. Epub 2018 Oct 1. Review.

23.

Making the most of the waiting room: Electronic patient engagement, a mixed methods study.

Coathup V, Finlay T, Teare HJ, Kaye J, South M, Watt FE, Luqmani R.

Digit Health. 2018 Jan 10;4:2055207617751304. doi: 10.1177/2055207617751304. eCollection 2018 Jan-Dec.

24.

An audit of the use of hydroxychloroquine in rheumatology clinics.

Worth C, Yusuf IH, Turner B, Gourier H, Brooks EE, Mort DO, Sharma S, Downes SM, Luqmani RA.

Rheumatol Adv Pract. 2018 May 8;2(1):rky013. doi: 10.1093/rap/rky013. eCollection 2018.

25.

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire.

Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, Ashdown S, Easley E, Gebhart D, Lanier G, Mills J, Peck J, Luqmani RA, Shea J, Tomasson G, Merkel PA.

Ann Rheum Dis. 2018 Aug;77(8):1157-1164. doi: 10.1136/annrheumdis-2017-212713. Epub 2018 Apr 25.

PMID:
29695498
26.

The European Vasculitis Society 2016 Meeting Report.

Bajema IM, Bruijn JA, Casian A, Cid MC, Csernok E, van Daalen E, Harper L, Hauser T, Little MA, Luqmani RA, Mahr A, Ponte C, Salama A, Segelmark M, Suzuki K, Sznajd J, Teng YKO, Vaglio A, Westman K, Jayne D.

Kidney Int Rep. 2017 Sep 21;2(6):1018-1031. doi: 10.1016/j.ekir.2017.09.008. eCollection 2017 Nov.

27.

Rheumatoid factor testing in Spanish primary care: A population-based cohort study including 4.8 million subjects and almost half a million measurements.

Morsley K, Miller A, Luqmani R, Fina-Aviles F, Javaid MK, Edwards CJ, Pinedo-Villanueva R, Medina M, Calero S, Cooper C, Arden N, Prieto-Alhambra D.

Reumatol Clin. 2019 Nov - Dec;15(6):350-354. doi: 10.1016/j.reuma.2017.11.001. Epub 2018 Feb 26. English, Spanish.

28.

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.

Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Patient Relat Outcome Meas. 2018 Jan 4;9:17-34. doi: 10.2147/PROM.S144992. eCollection 2018.

29.

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC.

Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Review.

30.

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Robson JC, Dawson J, Cronholm PF, Ashdown S, Easley E, Kellom KS, Gebhart D, Lanier G, Milman N, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Rheumatol Int. 2018 Apr;38(4):675-682. doi: 10.1007/s00296-017-3855-6. Epub 2017 Nov 9.

31.

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice.

Monti S, Floris A, Ponte CB, Schmidt WA, Diamantopoulos AP, Pereira C, Vaggers S, Luqmani RA.

Rheumatology (Oxford). 2018 Jan 1;57(1):112-119. doi: 10.1093/rheumatology/kex341.

PMID:
29045738
32.

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.

Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA.

Rheumatology (Oxford). 2017 Nov 1;56(11):1962-1969. doi: 10.1093/rheumatology/kex293.

PMID:
28968886
33.

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.

Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, Hellmich B, Holle J, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel P, Mills J, Mooney J, Segelmark M, Tesar V, Westman KWA, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

RMD Open. 2017 Jun 15;3(1):e000449. doi: 10.1136/rmdopen-2017-000449. eCollection 2017.

34.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

35.

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team.

N Engl J Med. 2017 May 18;376(20):1921-1932. doi: 10.1056/NEJMoa1702079.

36.

The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.

Monti S, Floris A, Ponte C, Schmidt WA, Diamantopoulos AP, Pereira C, Piper J, Luqmani R.

Rheumatology (Oxford). 2018 Feb 1;57(2):227-235. doi: 10.1093/rheumatology/kex173. Review.

37.

The RUDY study: using digital technologies to enable a research partnership.

Teare HJA, Hogg J, Kaye J, Luqmani R, Rush E, Turner A, Watts L, Williams M, Javaid MK.

Eur J Hum Genet. 2017 Jun;25(7):816-822. doi: 10.1038/ejhg.2017.57. Epub 2017 Apr 26.

38.

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

Goodfellow N, Morlet J, Singh S, Sabokbar A, Hutchings A, Sharma V, Vaskova J, Masters S, Zarei A, Luqmani R.

RMD Open. 2017 Mar 29;3(1):e000353. doi: 10.1136/rmdopen-2016-000353. eCollection 2017.

39.

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, Suppiah RS, Watts RA, Merkel PA, Luqmani RA.

Rheumatology (Oxford). 2017 Jul 1;56(7):1154-1161. doi: 10.1093/rheumatology/kex075.

40.

Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielsen SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2017 Jul;69(7):1470-1479. doi: 10.1002/art.40112. Epub 2017 Jun 9.

41.

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS).

Nakagomi D, Cousins C, Sznajd J, Furuta S, Mohammad AJ, Luqmani R, Jayne D.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):139-145. Epub 2017 Mar 13.

42.

Hydroxychloroquine retinopathy.

Yusuf IH, Sharma S, Luqmani R, Downes SM.

Eye (Lond). 2017 Jun;31(6):828-845. doi: 10.1038/eye.2016.298. Epub 2017 Mar 10. Review.

43.

Hydroxychloroquine retinopathy: an emerging problem.

Latasiewicz M, Gourier H, Yusuf IH, Luqmani R, Sharma SM, Downes SM.

Eye (Lond). 2017 Jun;31(6):972-976. doi: 10.1038/eye.2016.297. Epub 2017 Feb 10.

44.

The association of vascular risk factors with visual loss in giant cell arteritis.

Yates M, MacGregor AJ, Robson J, Craven A, Merkel PA, Luqmani RA, Watts RA.

Rheumatology (Oxford). 2017 Apr 1;56(4):524-528. doi: 10.1093/rheumatology/kew397.

PMID:
27940595
45.

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W, Masters S, McDonald B, McNally E, Pease C, Piper J, Salmon J, Wailoo A, Wolfe K, Hutchings A.

Health Technol Assess. 2016 Nov;20(90):1-238.

46.

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases.

Javaid MK, Forestier-Zhang L, Watts L, Turner A, Ponte C, Teare H, Gray D, Gray N, Popert R, Hogg J, Barrett J, Pinedo-Villanueva R, Cooper C, Eastell R, Bishop N, Luqmani R, Wordsworth P, Kaye J.

Orphanet J Rare Dis. 2016 Nov 8;11(1):150.

47.

Cryofibrinogenaemia-a neglected disease.

Moiseev S, Luqmani R, Novikov P, Shevtsova T.

Rheumatology (Oxford). 2017 Sep 1;56(9):1445-1451. doi: 10.1093/rheumatology/kew379. Review.

PMID:
27789759
48.

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

Ann Rheum Dis. 2016 Sep;75(9):1583-94. doi: 10.1136/annrheumdis-2016-209133. Epub 2016 Jun 23. Erratum in: Ann Rheum Dis. 2017 Aug;76(8):1480.

49.

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.

Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, Hamilton W, Emin A, Culliford D, Luqmani R.

J Rheumatol. 2016 Jun;43(6):1085-92. doi: 10.3899/jrheum.151024. Epub 2016 Apr 15.

PMID:
27084910
50.

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.

Robson JC, Milman N, Tomasson G, Dawson J, Cronholm PF, Kellom K, Shea J, Ashdown S, Boers M, Boonen A, Casey GC, Farrar JT, Gebhart D, Krischer J, Lanier G, McAlear CA, Peck J, Sreih AG, Tugwell PS, Luqmani RA, Merkel PA.

J Rheumatol. 2015 Nov;42(11):2204-9. doi: 10.3899/jrheum.141143. Epub 2015 Sep 1. Review.

Supplemental Content

Loading ...
Support Center